Pipeline

  Discovery
Candidate
Preclinical
Clinical
Partner
GPCR target for metabolic diseases +
Discovery
A2aR/A2bR antagonist +
Clinical
EP4 receptor antagonist ( DT-9081 ) +
Preclinical
Anti-CCR8 antibody +
Discovery
Undisclosed GPCR targets +
Discovery
Multi-target collaboration for CNS +
Discovery
mGluR4/7/8 PAM +
Candidate
NPFFR antagonist +
Discovery
Multi-target collaboration for rare diseases +
Discovery
CXCR4 biased agonist +
Discovery